Clinical Trial 23906

• Overview

  Study Title:

  Open-Label, Cohort-Sequential Dose-Escalation and Dose-Confirmation Phase 1/2 Clinical Trial to Evaluate the Safety and Efficacy of Domatinostat in Combination with Sirolimus in Adolescents and Adults with Relapsed, Refractory Sarcoma and Osteosarcoma

• Treatments

  Therapies:

  HDAC inhibitor; mTOR inhibitor

  Medications:

  Domatinostat (); Rapamune (Sirolimus); Rapamycin (Sirolimus); Sirolimus ()

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.